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A B S T R A C T
Chronic epiglottitis and supraglottitis are clinical entities that present with respiratory distress and are primarily
associated with autoimmune disorders, gastroesophageal reflux disease, or angioedema. First described in adults
with sarcoidosis in 2010, CO2 laser epiglottis resurfacing has been effective in reducing epiglottic edema. We
present two cases of adolescent males with non-granulomatous chronic supraglottitis who were successfully
treated with CO2 laser supraglottic resurfacing.
1. Introduction
There is a wide range of conditions which have been proposed to
cause supraglottitis including gastroesophageal reflux disease [1], in-
fections [2,3], allergies, hereditary angioedema [4], and amyloidosis
[5]. A number of rheumatologic diseases can also cause chronic su-
praglottitis including granulomatosis with polyangitis [6], systemic
lupus erythematosus [7], sarcoidosis [8], and chronic relapsing poly-
chondritis. Chronic non-granulomatous supraglottitis has been defined
to be chronic inflammation of the supraglottic larynx without evidence
of any specific cause [9]. The occurrence of chronic non-granulomatous
supraglottitis is very rare. There is limited literature describing this
entity, with only modest systemic improvement on steroid therapy, and
the potential for tracheotomy [9,10].
CO2 laser resurfacing of the epiglottis has previously been reported
as an effective way to reduce epiglottic edema in patients with lar-
yngeal sarcoidosis [8]. Given the clinical similarities of these two
conditions, we present two separate pediatric cases of non-granulo-
matous chronic supraglottitis from two different institutions and two
separate continents, which were successfully managed with a CO2 laser
resurfacing technique.
2. Case presentations
2.1. Case 1
A 15-year-old male presented to the emergency department (ED)
with a four-month history of odynophagia, dysphagia, increased
snoring, dyspnea on exertion, and a ten pound weight loss. He was
previously healthy without any significant past medical history. On
exam, flexible laryngoscopy revealed an edematous and inflamed epi-
glottis. His white blood cell count (WBC) and erythrocyte sedimenta-
tion (ESR) levels were normal at 11 and 7 respectively. The only ab-
normal laboratory value was an elevated C reactive protein (CRP) of
0.42. He was stable with no acute breathing difficulties, so he was
discharged from the ED on amoxicillin, ranitidine, and dexamethasone,
with plan for close follow up. One week later, he underwent a micro-
laryngoscopy and bronchoscopy (MLB) (Fig. 1) with biopsies of the
epiglottis, which revealed squamous non-keratinizing epithelial mucosa
with a lymphocytic component in the lamina propria, without evidence
of granulomas. Repeat biopsies two weeks later were consistent with
the above findings. Given this non-diagnostic result, he was subse-
quently evaluated by allergy and rheumatology. Both performed a
thorough work up with multiple tests including angiotensin converting
enzyme (ACE), complement, mannose binding lectin, lysozyme, im-
munoglobulin subclasses, lymphocyte subclasses, tuberculosis (TB), and
https://doi.org/10.1016/j.ijporl.2019.02.031
Received 13 November 2018; Received in revised form 17 February 2019; Accepted 18 February 2019
∗ Corresponding author. Division of Pediatric Otolaryngology, Head and Neck Surgery Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC
2018, Cincinnati, OH, 45229, USA.
E-mail address: mike.rutter@cchmc.org (M.J. Rutter).
International Journal of Pediatric Otorhinolaryngology 120 (2019) 162–165
Available online 20 February 2019
0165-5876/ © 2019 Elsevier B.V. All rights reserved.
T
anti-streptolysin O, all of which were within normal limits. With no
definitive diagnosis, we treated him with a CO2 laser resurfacing
(pepper-pot technique) of the epiglottis and arytenoids, similar to
previous patients with epiglottic edema secondary to sarcoidosis [8].
He underwent five separate CO2 laser epiglottis and arytenoid resur-
facing procedures every two to three weeks, for a total of ten total
procedures. For the fourth and fifth arytenoid treatments, triamcino-
lone was injected into the arytenoids after CO2 laser resurfacing. Se-
quential improvement was noted after each procedure (not complete
resolution of symptoms) and he was treated with the laser techniques
until there was complete resolution of symptoms and edema at the last
microlaryngoscopy (Fig. 2). There were no complications with his
treatment. He is currently doing well and has returned to all previous
activities without shortness of breath.
2.2. Case 2
A 15-year-old presented with 3 months of progressively worsening
snoring, inspiratory stridor, dyspnea on exertion, dysphagia and dys-
phonia. Initial laryngoscopy revealed supraglottic swelling with a thick
edematous epiglottis (Fig. 3a). There were no other airway pathologic
findings. Magnetic resonance imaging (MRI) demonstrated symmetric
supraglottic non-specific edema. Initial blood testing was normal (WBC,
ESR, CRP). The patient was admitted and treated with cefuroxime and
prednisolone. After five days of observation, he was discharged with
stable breathing on high-dose prednisone (40mg daily with slow taper
to 7.5mg daily over a 3 week period). He returned six days later for
MLB with biopsies of the epiglottis and lingual tonsils performed under
local anesthesia which revealed squamous non-keratinizing epithelial
mucosa with a lymphocytic component in the lamina propria, without
the evidence of granulomas. Extensive evaluations similar to the first
case by allergy, rheumatology, and pulmonology did not reveal a di-
agnosis.
Despite a lack of diagnosis, the patient was treated with a low dose
of prednisolone (7.5mg daily slowly tapered to 2.5mg every other day
over a four-month period) with resolution of stridor and difficulty
breathing at rest. After six months, he had persistent morning dys-
phagia and nausea, and dyspnea during exercise and underwent an
esophagogastroduodenoscopy (EGD) and MLB with biopsies. The find-
ings were consistent with the previous biopsies. Due to continued
Fig. 1. Case 1 - Initial microlaryngoscopy revealing an edematous epiglottis (A)
and arytenoids (B) prior to treatment.
Fig. 2. Case 1 – Final microlaryngoscopy of epiglottis (A) and arytenoids (B)
after CO2 laser treatments with pepper pot technique.
Fig. 3. Case 2 – Initial microlaryngoscopy revealing an edematous epiglottis
and arytenoids prior to treatment (A) and microlaryngoscopy after CO2 laser
treatments with pepper pot technique (B).
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dysphagia and dyspnea during exercise, the patient then underwent
CO2 laser resurfacing of the epiglottis and arytenoids [8]. After the first
treatment there was immediate resolution of the symptoms, but the
symptoms gradually returned in 2 months. The patient was treated with
a total of three separate procedures, spaced three months apart. After
his final treatment there was resolution of the symptoms and the lar-
yngeal edema had diminished (Fig. 3). He is currently doing well and
has returned to all previous activities without shortness of breath.
2.3. Surgical technique
The pepper pot technique, which was popularized by Sandhu and
colleagues for the treatment of chronic supraglottic edema due to sar-
coidosis, was utilized [8]. Using a large Lindholm laryngoscope for
exposure, the patient was suspended from the Mayo stand with the
Lewy bar system. A CO2 laser attached to a microscope was used (laser
settings of 5W, depth of 1, and a dot shape) with the patient sponta-
neously ventilating in case 1 and a laser reinforced tube for case 2. For
the epiglottis and arytenoids, the laser was used to make small, ap-
proximately 1–1.5mm, marks within the surface of the epiglottis which
were separated from each other by a small amount of mucosa (1–2mm)
in order to prevent scarring between adjacent sites (Fig. 4). The goal
depth was to reach the cartilage, in order to allow extrusion of the
edema, and cause mucosal scarring to the epiglottic cartilage to elim-
inate the potential space for fluid to collect. During initial treatments,
clear fluid was observed to drain from the laser holes, with this being
less evident with subsequent treatments.
3. Discussion
This study is the first to report the successful treatment of CO2 laser
supraglottic resurfacing in two pediatric patients with chronic idio-
pathic supraglottitis. Each of these patients was treated at two different
institutions among two different populations from two separate con-
tinents. Given the difficulty in managing this condition, and the simi-
larity in appearance with laryngeal sarcoidosis, we utilized the pepper
pot technique, described by Sandhu et al., for laryngeal edema in
sarcoidosis [8]. In each patient, CO2 laser supraglottis resurfacing re-
sulted in resolution of supraglottic edema and symptoms.
Chronic supraglottitis and epiglottitis are rare, but when they occur
a broad diagnostic work up is often indicated. Given the incidence of
gastroesophageal reflux and infectious diseases as underlying risk fac-
tors, an antireflux regimen and investigation for viral, bacterial, fungal,
tuberculosis, and syphilis as potential causes is warranted [1–3]. In
patients where the etiology is not clearly infectious or reflux related, a
multidisciplinary approach is beneficial to assist in evaluating for al-
lergies and systemic inflammatory conditions such as sarcoidosis,
granulomatosis with polyangitis, or systemic lupus erythematosus
[4–7]. If repeated biopsies and other evaluations are negative, previous
literature suggests with continued observation patients will have per-
sistent supraglottic edema, and they intermittently may require ster-
oids, hospital admission, or even tracheotomy [9].
There is only one study to report the treatment of chronic non-
granulomatous supraglottitis with local triamcinolone injections with
moderate response [9]. Sandhu et al. reported ten patients with su-
praglottic sarcoidosis that were successfully treated with a median of
two CO2 laser resurfacing (range of 1–4 treatments) with simultaneous
triamcinolone injections [8]. Using this technique, our patients had
resolution of their laryngeal edema without any adverse effects. Due to
a lack of treatment algorithm and surgeon preference, one underwent
four treatments and one underwent ten.
As this technique was only attempted on two cases of chronic non-
granulomatous epiglottitis, it is not possible to report a treatment al-
gorithm or success rate. However, this study demonstrates the safety,
efficacy and feasibility of treating pediatric chronic idiopathic su-
praglottitis. In addition to the surgical treatments, the second case was
treated with a longer duration of steroids which could have led to the
resolution of symptoms between treatments. Further study is warranted
among this patient population to determine if this is effective for other
cases of chronic idiopathic supraglottitis.
4. Conclusion
We report two cases of teenage male patients who presented with
chronic idiopathic supraglottitis. Each patient was managed similarly
and the CO2 laser pepper pot technique, popularized by Sandhu for the
treatment of laryngeal sarcoidosis, was effective in treating the edema
and eliminating the symptoms.
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